Rajendra Prasad Roy (born 26 January 1962) is an Indian chemical biologist, biochemist and a scientist at the National Institute of Immunology.[1] Known for his studies in protein engineering, Roy has developed several chemo-enzymatic strategic processes[2] for which he has a patent assigned to him.[note 1] He holds a PhD from the Indian Institute of Science[3] and is an elected fellow of all the three major Indian science academies namely Indian National Science Academy,[4] Indian Academy of Sciences,[5] and National Academy of Sciences, India.[6] The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for him contributions to biosciences in 2005.[7]Currently he is the dean of Regional Centre for Biotechnology, Faridabad.[8]
Rajendra Prasad Roy | |
|---|---|
| Born | 26 January 1962 India |
| Nationality | Indian |
| Alma mater | |
| Known for | Studies in protein engineering |
| Awards |
|
| Scientific career | |
| Fields | |
| Institutions | |
Patents
- Roy, Rajendra Prasad; Samantaray, Sharmishtha. "US Patent for Bioconjugates as therapeutic agent and synthesis thereof". patents.justia.com. Patent # 8,148,321 issued 3 April 2012. Retrieved 17 December 2017.
See also
Notes
References
External links
- Appaiahgari, Mohan Babu; Vrati, Sudhanshu (2007). "DNAzyme-mediated Inhibition of Japanese Encephalitis Virus Replication in Mouse Brain". Molecular Therapy. 15 (9): 1593–1599. doi:10.1038/sj.mt.6300231. PMID 17579579.